Fluidigm (FLDM) got here out with a quarterly lack of $0.09 per share according to the Zacks Consensus Estimate. This compares to lack of $0.38 per share a 12 months in the past. These figures are adjusted for non-recurring gadgets.
1 / 4 in the past, it was anticipated that this firm that makes tools to manage fluids would submit a lack of $0.08 per share when it truly produced a lack of $0.10, delivering a shock of -25%.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates simply as soon as.
Fluidigm, which belongs to the Zacks Medical – Devices trade, posted revenues of $26.50 million for the quarter ended September 2019, lacking the Zacks Consensus Estimate by 8.15%. This compares to year-ago revenues of $28.96 million. The corporate has topped consensus income estimates two occasions during the last 4 quarters.
The sustainability of the inventory’s speedy value motion based mostly on the recently-released numbers and future earnings expectations will largely depend upon…